EAM Investors, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2020$1,628,000
+54.8%
164,400
+20.8%
0.36%
+10.1%
Q1 2020$1,052,000
+21.1%
136,098
+26.6%
0.33%
+38.6%
Q4 2018$869,000
-54.2%
107,531
-26.9%
0.24%
-16.3%
Q3 2018$1,899,000
-6.8%
147,184
-17.6%
0.28%
-12.1%
Q2 2018$2,037,000
+236.1%
178,690
+107.9%
0.32%
+217.8%
Q1 2018$606,00085,9670.10%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders